Susceptibility and Prognosis of COVID-19 Patients with Cardiovascular Disease

Overview

Journal Open Heart

Publisher BMJ Publishing Group

Specialty Cardiology & Vascular Diseases

Date 2020 Jun 27

PMID 32587104

Citations 5

Authors

Brian Xiangzhi Wang

Affiliations

Soon will be listed here.

Citing Articles

Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity.

Vukcevic M, Serovic K, Despot M, Nikolic-Kokic A, Vujovic A, Nikolic M Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256955 PMC: 10818859. DOI: 10.3390/ph17010122.

Multivariable Risk Modelling and Survival Analysis with Machine Learning in SARS-CoV-2 Infection.

Ciarmiello A, Tutino F, Giovannini E, Milano A, Barattini M, Yosifov N J Clin Med. 2023; 12(22).

PMID: 38002776 PMC: 10672177. DOI: 10.3390/jcm12227164.

The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System.

AlQahtani M, Abbas M, Alsabaani A, Alqarni A, Almohiy H, Alsawqaee E Infect Drug Resist. 2022; 15:1175-1189.

PMID: 35345472 PMC: 8957310. DOI: 10.2147/IDR.S351318.

COVID-19 and RAAS inhibitors: is there a final conclusion?.

Talebi-Taher M, Najafi M, Behzad S Iran J Microbiol. 2022; 13(6):728-736.

PMID: 35222849 PMC: 8816704. DOI: 10.18502/ijm.v13i6.8071.

Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: A population-based cohort study from Italy.

Orlando V, Rea F, Savare L, Guarino I, Mucherino S, Perrella A PLoS One. 2021; 16(1):e0237202.

PMID: 33471809 PMC: 7816996. DOI: 10.1371/journal.pone.0237202.

References

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Akhmerov A, Marban E . COVID-19 and the Heart. Circ Res. 2020; 126(10):1443-1455. DOI: 10.1161/CIRCRESAHA.120.317055. View

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Schoeman D, Fielding B . Coronavirus envelope protein: current knowledge. Virol J. 2019; 16(1):69. PMC: 6537279. DOI: 10.1186/s12985-019-1182-0. View

Mehra M, Desai S, Kuy S, Henry T, Patel A . Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020; 382(25):e102. PMC: 7206931. DOI: 10.1056/NEJMoa2007621. View

. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41(2):145-151. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003. View

Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G . Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. 2020; 382(25):2431-2440. PMC: 7206933. DOI: 10.1056/NEJMoa2006923. View

Stralin K, Holmberg H . Causes of death for patients with community-acquired pneumonia. Arch Intern Med. 2002; 162(21):2491-2; author reply 2492-3. DOI: 10.1001/archinte.162.21.2491. View

10.

Reynolds H, Adhikari S, Pulgarin C, Troxel A, Iturrate E, Johnson S . Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19. N Engl J Med. 2020; 382(25):2441-2448. PMC: 7206932. DOI: 10.1056/NEJMoa2008975. View

11.

Yu C, Wong R, Wu E, Kong S, Wong J, Yip G . Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006; 82(964):140-4. PMC: 2596695. DOI: 10.1136/pgmj.2005.037515. View

12.

Yoon H, Kim E, Kim M, Lim J, Jang I, Ban T . Age-Associated Changes in the Vascular Renin-Angiotensin System in Mice. Oxid Med Cell Longev. 2016; 2016:6731093. PMC: 4855022. DOI: 10.1155/2016/6731093. View

13.

Ferrario C, Jessup J, Chappell M, Averill D, Brosnihan K, Tallant E . Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005; 111(20):2605-10. DOI: 10.1161/CIRCULATIONAHA.104.510461. View